Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is a global medical technology leader headquartered in Warsaw, Indiana, USA. The company's mission is to alleviate pain and improve the quality of life for people around the world. Founded in 1927, Zimmer Biomet designs, manufactures, and markets a comprehensive portfolio of musculoskeletal healthcare solutions.

Its key offerings include orthopedic reconstructive products such as knee, hip, shoulder, elbow, foot, and ankle artificial joints, as well as sports medicine, biologics, extremities, and trauma products. The company also provides spine, bone healing, craniomaxillofacial, and thoracic products, dental implants, and related surgical products. Zimmer Biomet integrates digital and robotic technologies, including its ROSA robotic platform (for knee, hip, and shoulder replacement), Persona IQ smart implants, and the ZBEdge digital suite, to enhance surgical procedures and patient outcomes.

Ivan Tornos serves as the Chairman, President, and Chief Executive Officer, having been appointed CEO in August 2023 and Chairman in May 2025. In April 2026, Paul Stellato was named interim Chief Financial Officer. The company reported strong first-quarter 2026 financial results, with increased net sales and diluted earnings per share, and completed $250 million in share repurchases. Zimmer Biomet maintains a position as a global top-three vendor in orthopedic reconstruction, with significant market share in knee and hip implants, and continues to invest in advanced technologies like robotics and AI through strategic acquisitions such as OrthoGrid Systems (announced August 2024) and planned acquisition of Monogram Technologies (July 2025).